Millennium Management
ONSIW

Millennium Management’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Millennium Management’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43,525
Closed -$21K – 3943
2016
Q3 		$21K Sell
43,525
-1,400
-3% -$637 ﹤0.01% 3213
2016
Q2 		$21K Buy
+44,925
New +$17.2K ﹤0.01% 3104

Other funds holding ONSIW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's ONSIW Position: Q4 2016 in Review

Millennium Management sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2016, closing a stake of 43,525 shares — an estimated $21K sold.

Millennium Management first reported a position in ONSIW in Q2 2016 and held it in 2 quarters. The position peaked at $21K in Q3 2016. 11 funds tracked by Wall St. Rank hold ONSIW as of Q4 2016.

  • Millennium Management reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2016 after selling out during the quarter.
  • Millennium Management sold 43,525 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2016, an estimated $21K.
  • Millennium Management first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 2 quarters.
  • Millennium Management's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $21K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.